Teicoplanin for skin and soft tissue infections: An open study and a randomized, comparative trial versus cefazolin
- 1 January 1999
- journal article
- Published by Elsevier BV in Journal of Infection and Chemotherapy
- Vol. 5 (1), 40-45
- https://doi.org/10.1007/s101560050006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Streptococcal Infections of Skin and Soft TissuesNew England Journal of Medicine, 1996
- Streptococcal Toxic-Shock Syndrome: Spectrum of Disease, Pathogenesis, and New Concepts in TreatmentEmerging Infectious Diseases, 1995
- Colonization and Infection with Antibiotic‐Resistant Bacteria in a Long‐Term Care FacilityJournal of the American Geriatrics Society, 1994
- Randomized Comparison Trial of Teicoplanin IV, Teicoplanin IM, and Cefazolin Therapy for Skin and Soft Tissue Infections Caused by Gram-Positive BacteriaSouthern Medical Journal, 1994
- The Current Spectrum of Staphylococcus aureus Infection in a Tertiary Care HospitalMedicine, 1994
- Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus— a comparative study of conventional radiometric function tests and low‐light imaging systemsJournal of Bioluminescence and Chemiluminescence, 1994
- Teicoplanin in the treatment of skin and soft tissue infections: Results of a multicentre studyInfection, 1991
- A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1988
- Teicoplanin in the treatment of skin and soft tissue infectionsJournal of Antimicrobial Chemotherapy, 1988
- In vitro activity of teichomycin compared with those of other antibioticsAntimicrobial Agents and Chemotherapy, 1983